Ever Had Chicken Pox? Approximately 1 in every 3 adults who had Chicken Pox will get Shingles
You may qualify to participate in a national research study to evaluate the safety and effectiveness of the shingles vaccine (Zostavax®). Are you at least 50 years in age? Are you taking Remicade, Enbrel, Humira, Cimzia or Simponi? If yes, and if you have never received the shingles vaccine, you may qualify. The study requires 2 in-person visits, spaced 6 weeks apart. Participants will be compensated $100 for completing the study.
Zostavax ® is an approved vaccine for people ages 50 and older and has been shown to be very effective to prevent zoster (shingles) and related complications. However it has NOT been studied in patients who are taking Remicade, Enbrel, Humira, Cimzia or Simponi.
The Varicella zostER VaccinE Study (VERVE) has been approved by the Food and Drug Administration (FDA)
For more information, please call the UAB VERVE Study at (205) 934-2993 or email verve@uab.edu
The University of Alabama at Birmingham (UAB) is coordinating the VERVE study.
Click here for information for clinicians